These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 27716388

  • 1. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD, Sasaki MM, Onel K.
    Breast Cancer Res; 2016 Oct 03; 18(1):99. PubMed ID: 27716388
    [Abstract] [Full Text] [Related]

  • 2. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    Aloraifi F, Boland MR, Green AJ, Geraghty JG.
    Surg Oncol; 2015 Jun 03; 24(2):100-9. PubMed ID: 25936246
    [Abstract] [Full Text] [Related]

  • 3. Genetic risk of breast cancer.
    Nasir A, Shackelford RE, Anwar F, Yeatman TJ.
    Minerva Endocrinol; 2009 Dec 03; 34(4):295-309. PubMed ID: 20046159
    [Abstract] [Full Text] [Related]

  • 4. BRCA and beyond: a genome-first approach to familial breast cancer risk assessment.
    Trainer AH, Thompson E, James PA.
    Discov Med; 2011 Nov 03; 12(66):433-43. PubMed ID: 22127114
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery.
    Chandler MR, Bilgili EP, Merner ND.
    Hum Mutat; 2016 Sep 03; 37(9):835-46. PubMed ID: 27226120
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    Wendt C, Margolin S.
    Acta Oncol; 2019 Feb 03; 58(2):135-146. PubMed ID: 30606073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
    Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D.
    Genet Epidemiol; 2001 Jul 03; 21(1):1-18. PubMed ID: 11443730
    [Abstract] [Full Text] [Related]

  • 14. Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
    Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G.
    J Clin Oncol; 2006 Feb 20; 24(6):863-71. PubMed ID: 16484695
    [Abstract] [Full Text] [Related]

  • 15. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.
    J Clin Oncol; 2002 Jun 01; 20(11):2701-12. PubMed ID: 12039933
    [Abstract] [Full Text] [Related]

  • 16. Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.
    Sapkota Y.
    Cytogenet Genome Res; 2014 Jun 01; 144(2):77-91. PubMed ID: 25401968
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F, Alshehhi M, McDevitt T, Cody N, Meany M, O'Doherty A, Quinn CM, Green AJ, Bracken A, Geraghty JG.
    Eur J Surg Oncol; 2015 May 01; 41(5):641-6. PubMed ID: 25736863
    [Abstract] [Full Text] [Related]

  • 18. Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families.
    Balleine RL, Provan PJ, Pupo GM, Pathmanathan N, Cummings M, Farshid G, Salisbury EL, Bilous AM, Byth K, KConFab Investigators, Mann GJ.
    Genes Chromosomes Cancer; 2010 Dec 01; 49(12):1082-94. PubMed ID: 20815029
    [Abstract] [Full Text] [Related]

  • 19. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
    Gracia-Aznarez FJ, Fernandez V, Pita G, Peterlongo P, Dominguez O, de la Hoya M, Duran M, Osorio A, Moreno L, Gonzalez-Neira A, Rosa-Rosa JM, Sinilnikova O, Mazoyer S, Hopper J, Lazaro C, Southey M, Odefrey F, Manoukian S, Catucci I, Caldes T, Lynch HT, Hilbers FS, van Asperen CJ, Vasen HF, Goldgar D, Radice P, Devilee P, Benitez J.
    PLoS One; 2013 Dec 01; 8(2):e55681. PubMed ID: 23409019
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.